Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Recruiting · NCT07566195 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 3 | 2026-08-27 | NCT07566195 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Clinact, Multihealth Group | 1 |
| Contract Research Organization | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||